Related Experiment Video
Updated: Nov 18, 2025

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
Published on: June 25, 2010
The first Saudi baby with classic homocystinuria diagnosed by universal newborn screening
Talal AlAnzi1, Fahad J Al Harbi1, Joharah AlFaifii1
1From the Department of Pediatrics (AlAnzi, Mohamed); from the Department of Biochemical laboratory (Al Harbi, AlFaifi), Prince Sultan Military Medical City; from the Prince Abdullah bin Khalid Celiac Disease Research Chair (Mohamed), King Saud University; and from the Department of Pediatrics (Mohamed), College of Medicine, AlFaisal University, Riyadh, Kingdom of Saudi Arabia.
Insights
Newborn screening effectively diagnosed classic homocystinuria (CH) in a Saudi infant, enabling early intervention. This highlights the feasibility and impact of universal newborn screening for preventing severe metabolic disease complications.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Classic homocystinuria (CH) is a severe inherited metabolic disorder due to cystathionine beta-synthase deficiency.
- Early diagnosis and treatment are crucial to prevent intellectual disability and other complications in affected infants.
Observation:
- Routine newborn screening (NBS) using tandem mass spectrometry (MSMS) detected elevated methionine levels in an infant.
- Elevated total serum homocysteine confirmed the diagnosis of classic homocystinuria.
Findings:
- This case represents the first Saudi infant diagnosed with homocystinuria via universal NBS.
- Prompt medical and dietary management was initiated following diagnosis.
Implications:
- Universal NBS for CH is a feasible and effective strategy for early detection.
- Timely intervention through NBS can significantly reduce the disease burden and prevent long-term complications.
Abstract:
Classic homocystinuria (CH) is an inborn error of metabolism caused by cystathionine beta-synthase enzyme deficiency. Affected patients present with intellectual disability and other comorbidities. If diagnosed early in infancy and started treatment, inevitable complications can be prevented. Newborn screening (NBS) uses tandem mass-spectroscopy (MSMS) to measure the amino acid levels. In CH, the first-tier screening test is the measurement of methionine by MSMS. If methionine remained elevated in the recall sample, plasma level for homocysteine is performed. A newborn infant underwent routine NBS in our institute that showed elevated methionine in the first and the recall sample. Thereafter, total serum homocysteine was found to be elevated, consistent with the diagnosis of CH. An early medical and dietary management was commenced for this first Saudi baby diagnosed with homocystinuria by universal NBS. This report demonstrates that NBS for CH is feasible and effective in preventing the disease burden.
Related Concept Videos
Inborn Errors of Metabolism
Serum Laboratory Studies, Stool Test, Breath Test
Amines to Sulfonamides: The Hinsberg Test
Generally, a primary amine reacts with the Hinsberg reagent to produce an N-substituted benzenesulfonamide. The electron-withdrawing sulfonyl...
Pedigree Analysis
Acute Kidney Injury IV: Diagnostic Studies and Prevention

